Sep 14, 2021 11:00am EDT bioAffinity Technologies Announces Precision Pathology Services’ Validation of Novel Non-Invasive Early Lung Cancer Test
Aug 12, 2021 11:00am EDT bioAffinity Technologies Publishes Sputum Processing and Innovative High-Throughput Analysis Methods
Jun 23, 2021 11:00am EDT bioAffinity Technologies Presents Scientific Discoveries Advancing Cancer Therapeutics and Diagnostics at Two Global Conferences
Mar 03, 2021 11:00am EST Leading Cell Biology Journal Publishes bioAffinity Technologies’ Groundbreaking Research on Porphyrins
Feb 04, 2021 10:00am EST bioAffinity Technologies Executes Agreement with Fosun Long March to Evaluate CyPath® Lung for Commercialization in China
Nov 10, 2020 11:00am EST bioAffinity Technologies to Present at 2020 American Society of Cell Biology Meeting
Oct 22, 2020 10:00am EDT bioAffinity Technologies to Present Poster at World Conference on Lung Cancer 2020
Oct 15, 2020 10:00am EDT Smiths Medical and bioAffinity Technologies Partner to Advance Non-Invasive Testing for Early Lung Cancer
Sep 29, 2020 11:00am EDT bioAffinity Technologies Announces Dr. Martin Tammemägi to Chair Scientific and Medical Advisory Board
Aug 12, 2020 10:00am EDT Precision Pathology Services and bioAffinity Technologies Announce Initiation of CLIA Validation for Non-Invasive Early Lung Cancer Test
